Value-Based Pricing in Malaysia’s Healthcare: A stakeholder analysis

Background: High pharmaceutical price is a dilemma. Value-based pricing (VBP) is suggested to be the potential solution to this problem. However, in Malaysia, VBP does not receive favorable response from the industry players. Therefore, in this study we would like to examine the position of various...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Asia Pacific Journal of Health Management
المؤلفون الرئيسيون:	Amirul Ashraf, Siew Chin Chin Ong
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	ACHSM 2022-07-01
الموضوعات:	value based pricing, pharmaceutical policy, price regulation, stakeholder analysis
الوصول للمادة أونلاين:	http://journal.achsm.org.au/index.php/achsm/article/view/735

مواد مشابهة

Multi stakeholders of health and industries perspectives on medicine price transparency initiative in private health care settings in Malaysia
حسب: Nur Sufiza Ahmad, وآخرون
منشور في: (2020-07-01)

Association between medicine Price declaration by pharmaceutical industries and retail prices in Malaysia’s private healthcare sector
حسب: Nur Sufiza Ahmad, وآخرون
منشور في: (2019-12-01)

Stakeholder engagement and pharmaceutical pricing regulation: a qualitative inquiry
حسب: Ye Shing Lourdes Loh, وآخرون
منشور في: (2025-12-01)

Indication-wide drug pricing: Insights from the pharma market
حسب: Florian Siegmeier, وآخرون
منشور في: (2022-12-01)

Government pharmaceutical pricing strategies in the Asia-Pacific region: an overview
حسب: Naina R. Verghese, وآخرون
منشور في: (2019-01-01)

Timely, Cheap, or Risk-Free? The Effect of Regulation on the Price and Availability of New Drugs
حسب: Laura Levaggi, وآخرون
منشور في: (2024-03-01)

Branded prescription drug spending: a framework to evaluate policy options
حسب: Jeromie Ballreich, وآخرون
منشور في: (2017-12-01)

IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET
حسب: V. A. Lemeshko, وآخرون
منشور في: (2018-02-01)

Pricing Strategies Evaluation in Radio Industry's Firm (Case Study at PT XYZ)
حسب: Halimatussakdiah Halimatussakdiah, وآخرون
منشور في: (2021-01-01)

Generic Medicine Pricing Policies in Europe: Current Status and Impact
حسب: Pieter Dylst, وآخرون
منشور في: (2010-03-01)

Assessing the Consequences of External Reference Pricing for Global Access to Medicines and Innovation: Economic Analysis and Policy Implications
حسب: András Incze, وآخرون
منشور في: (2022-04-01)

Drivers of innovation value: simulation for new drug pricing evaluation based on system dynamics modelling
حسب: Qian Xing, وآخرون
منشور في: (2025-01-01)

How does external reference pricing work in developing countries: evidence from Iran
حسب: Fatemeh Babaie, وآخرون
منشور في: (2023-06-01)

Drug pricing and reimbursement decision making systems in Mongolia
حسب: Gereltuya Dorj, وآخرون
منشور في: (2017-12-01)

The price of innovation - the role of drug pricing in financing pharmaceutical innovation. A conceptual framework
حسب: Santiago G. Moreno, وآخرون
منشور في: (2019-01-01)

Is There Any Regional Price Disparity in Peninsular Malaysia?
حسب: LEE CHIN
منشور في: (2015-06-01)

Evaluating Price and Availability of Essential Medicines in China: A Mixed Cross-Sectional and Longitudinal Study
حسب: Caijun Yang, وآخرون
منشور في: (2020-11-01)

Pricing strategy and firms profitability
حسب: Ibrahim Tahat
منشور في: (2023-12-01)

Effects of a price cut reform on the cost and utilization of antidiabetic drugs in Korea: a national health insurance database study
حسب: Hae Sun Suh, وآخرون
منشور في: (2018-06-01)

COMPARATIVE ANALYSIS OF STRATEGIES OF PRICING AND PROMOTION OF PRODUCTS AND SERVICES ON NETWORK VALUES MARKET
حسب: Viktor E. Dementiev, وآخرون
منشور في: (2019-06-01)

The impact of external reference pricing on pharmaceutical costs and market dynamics
حسب: Dominic Voehler, وآخرون
منشور في: (2023-12-01)

APPLICATIONS OF FAIR VALUE PRICING
حسب: Valentin Gabriel CRISTEA
منشور في: (2019-05-01)

PRICE CATEGORIES AND PRICE STRUCTURE
حسب: VĂDUVA CECILIA ELENA
منشور في: (2014-02-01)

Effects of transparent online open procurement on prices, volumes, and costs of medicines: an interrupted time series study in Ningxia, China
حسب: Jingying Gao, وآخرون
منشور في: (2024-08-01)

Managing new premium-priced medicines in Europe
حسب: Govin Permanand, وآخرون
منشور في: (2015-12-01)

Research of factors of marketing pricing at domestic industrial enterprises
حسب: V.V. Bozhkova, وآخرون
منشور في: (2013-06-01)

Impact of regulated price adjustments on price variability in a very low inflation transition economy: Case of Armenia
حسب: Aghassi Mkrtchyan
منشور في: (2005-06-01)

New Insights into the Price Dynamics of Prescription Pharmaceuticals in Slovenia over the Period 2001–2014
حسب: Petra Došenović Bonča, وآخرون
منشور في: (2017-11-01)

PENGARUH PRICE EARNING RATIO DAN UKURAN PERUSAHAAN TERHADAP PRICE BOOK VALUE
حسب: Dwi Putri Susilowaty Sugiarto
منشور في: (2017-04-01)

Pharmaceutical pricing policy in Greece: towards a different path.
حسب: Kyriakos Souliotis, وآخرون
منشور في: (2016-08-01)

A comparison of generic drug prices in seven European countries: a methodological analysis
حسب: Olivier J. Wouters, وآخرون
منشور في: (2017-03-01)

Impact of discounts on medicine prices
حسب: Peter Schneider, وآخرون
منشور في: (2015-12-01)

Neutrality of the Regulated Price Shock on Price Indices When All Primary Factors’ Endowments Are Adjusted
حسب: Nooraddin Sharify
منشور في: (2014-04-01)

How Effective are Price Regulator’s Price Control Measures?
حسب: Biman Prasad, وآخرون
منشور في: (2023-11-01)

LEVERAGE AND IPO PRICING: EVIDENCE FROM MALAYSIA
حسب: Chui Zi Ong, وآخرون
منشور في: (2020-03-01)

Evaluating the impact of price regulation (Drug Price Control Order 2013) on antibiotic sales in India: a quasi-experimental analysis, 2008–2018
حسب: Sakthivel Selvaraj, وآخرون
منشور في: (2022-12-01)

International positioning of South African electricity prices and commodity differentiated pricing
حسب: George A. Thopil, وآخرون
منشور في: (2013-07-01)

Dynamic Pricing in a Multi-Period Newsvendor Under Stochastic Price-Dependent Demand
حسب: Mehran Ullah, وآخرون
منشور في: (2019-06-01)

External reference pricing for medicines in Ukraine: latest trends
حسب: L. I. Kucherenko, وآخرون
منشور في: (2023-11-01)

Monitoring of the assortment structure and price dynamics of hepatoprotectors in the modern Ukrainian pharmaceutical market
حسب: I. O. Pukhalska, وآخرون
منشور في: (2020-11-01)